Benzinga | Apr 13, 2021 07:33AM EDT

RBC Capital Initiates Coverage On OptimizeRx with Outperform Rating, Announces Price Target of $65

RBC Capital analyst Sean Dodge initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Outperform rating and announces Price Target of $65.